Source:http://linkedlifedata.com/resource/pubmed/id/15946987
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-8-1
|
pubmed:abstractText |
Linezolid, the first available agent in the new class of oxazolidinone antibiotics, represents a significant advance in the management options available for combating methicillin-resistant Staphylococcus aureus (MRSA) infections. In the UK it was launched for clinical use in 2001. The aim of this study was to audit the clinical use of linezolid and compliance with the guidelines of the hospital antibiotic committee.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
423-6
|
pubmed:dateRevised |
2006-7-5
|
pubmed:meshHeading |
pubmed-meshheading:15946987-Acetamides,
pubmed-meshheading:15946987-Aged,
pubmed-meshheading:15946987-Anti-Bacterial Agents,
pubmed-meshheading:15946987-Bacterial Infections,
pubmed-meshheading:15946987-Drug Utilization Review,
pubmed-meshheading:15946987-Great Britain,
pubmed-meshheading:15946987-Hospitals, Teaching,
pubmed-meshheading:15946987-Humans,
pubmed-meshheading:15946987-Oxazolidinones
|
pubmed:year |
2005
|
pubmed:articleTitle |
Clinical audit of linezolid use in a large teaching hospital.
|
pubmed:affiliation |
Department of Infection, Ninewells Hospital & Medical School, Dundee DD1 9SY, UK. hziglam@doctors.org.uk
|
pubmed:publicationType |
Journal Article
|